Ingenuity Systems said this week that it is partnering with GeneInsight, a wholly owned subsidiary of Partners HealthCare, to develop an integrated workflow solution that will include tools for annotating, analyzing, assessing, and reporting human variants from next-generation sequencing-based tests.
Heidi Rehm, chief laboratory director of Partners' laboratory for molecular medicine, said in a statement that "the combined solution will incorporate knowledge about genomic variation from the Ingenuity offering with GeneInsight's knowledge management and reporting infrastructure, helping to streamline the overall workflow for very broad spectrum tests.”
Under the terms of the agreement, Ingenuity will provide content and software for the analysis and biological interpretation of variants from sequencing-based tests. GeneInsight will provide genetic testing laboratories and providers with networked infrastructure to support interpretation, reporting, and management of genetic data.
Additional details were not disclosed.